Physician profile
Meha Fox
NPI 1982099644
$12,258.84
in general payments reported to CMS, 2019-2025
19 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $207 · 2021: $314 · 2022: $1,551 · 2023: $1,762 · 2024: $8,062 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,510 · Food and Beverage: $2,827 · Travel and Lodging: $829 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,509.95 |
| Food and Beverage | $2,827.26 |
| Travel and Lodging | $829.31 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $7,899.17 | 2021-2025 | |
| Genzyme Corporation | $1,544.01 | 2023-2024 | |
| Acclarent, INC | $630.82 | 2021-2023 | Trudi Nav Cable, Trudi Nav Suction, Acclarent Navwire |
| Medtronic, INC. | $504.63 | 2022-2024 | Propel |
| Inspire Medical Systems, INC. | $345.92 | 2020-2024 | Inspire |
| Integra Lifesciences Corporation | $308.65 | 2023-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Stryker Corporation | $302.15 | 2022-2024 | |
| Olympus America INC. | $248.97 | 2022-2024 | Rhino-Laryngo Videoscope |
| Smith+Nephew, INC. | $110.30 | 2023-2025 | Stravix Pl, Grafix Pl, Stravix |
| Neurent Medical Limited | $74.33 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Intersect Ent, INC. | $59.90 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $56.35 | 2024 | Fasenra |
| Glaxosmithkline, LLC. | $51.99 | 2024 | Nucala |
| Aroa Biosurgery Incorporated | $25.01 | 2023 | |
| Ets Wound Care LLC | $23.29 | 2024 | Mirragen Advanced Wound Matrix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $20.80 | 2025 | |
| Acell, INC. | $19.32 | 2020 | |
| Paratek Pharmaceuticals, INC. | $16.72 | 2025 | Xhance |
| Tactile Systems Technology INC | $16.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meha Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.